Is BG a Buy or a Sell? The Bull and Bear Case (2026)
Last updated July 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Bunge Global SA (BG) rests on Viterra merger scale and synergies: The completed Viterra combination roughly doubles Bunge's trailing revenue base toward $70 billion and adds a leading grain-trading and origination network to Bunge's oilseed-processing strength. The bear case rests on bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply. Analysts covering it publish targets from $116.00 to $150.00 against a $108.79 price, so even the professionals disagree by 24% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
Bunge Global SA is a leading global agribusiness and food company that sources, stores, processes, transports, and sells agricultural commodities and food ingredients. It sits among the "ABCD" grain traders (ADM, Bunge, Cargill, Louis Dreyfus) and reports across three segments: Agribusiness (high-volume, low-margin oilseed processing and grain merchandising), Refined and Specialty Oils, and Milling. In July 2025 Bunge closed its roughly $8 billion merger with Glencore-backed Viterra, combining the top oilseed processor with a leading grain trader to form a group valued near $25 billion, and it sold its North American corn milling business the same month. The investment picture is one of scale plus cyclicality. Trailing revenue has jumped to roughly $70 billion as Viterra consolidates, but profitability is driven by the crush spread (the gap between soybean meal and oil prices and the cost of raw soybeans), which swings with harvests, biofuel demand, and trade policy. After a down year in 2024 and softer 2025, analysts model an earnings recovery in 2026 and 2027 as Viterra synergies and a broader footprint kick in, but the payoff depends on integration execution and a commodity backdrop Bunge does not control.
The bull case: what would have to be true for $150.00
The most optimistic published target on BG is $150.00, +37.9% from the $108.79 price as of July 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Viterra merger scale and synergies
The completed Viterra combination roughly doubles Bunge's trailing revenue base toward $70 billion and adds a leading grain-trading and origination network to Bunge's oilseed-processing strength. Management frames the deal as a way to smooth commodity volatility through a more diversified and geographically balanced footprint. Realizing the targeted cost and volume synergies is the central multi-year driver of the earnings story.
2. Crush margins and biofuel demand
Core Agribusiness profitability tracks the crush spread, which is sensitive to soybean oil demand from renewable diesel and biofuel policy alongside global protein-meal consumption. Firm biofuel feedstock demand can lift oil values and widen crush economics. A sustained 10% move in average crush margins can swing annual EPS by roughly 8 to 12%, making this the single biggest earnings lever.
3. Portfolio reshaping and capital returns
Bunge has been pruning and reshaping, including selling its North American corn milling business in mid-2025, to focus capital on higher-return processing and value-added oils. The company pays a dividend yielding around 3% with a payout ratio near the mid-50s percent, leaving room for reinvestment in growth projects across its global plant network.
4. Earnings recovery expectations into 2026 and 2027
After adjusted EPS stepped down to roughly $7.57 in 2025 from higher prior-year levels, consensus models a rebound toward the mid-$9 range in 2026 and higher in 2027, largely on Viterra contribution and normalizing margins. That recovery is the crux of the forward valuation, which trades at a lower multiple on next year's expected earnings than on trailing results.
The bear case: what would have to be true for $116.00
The most pessimistic published target is $116.00, +6.6% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Bunge Global SA is worth if the risks below bite instead of the drivers above.
Bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply. Expanded soybean and corn production in Brazil and Argentina intensifies competition and can pressure US export economics and margins. Integrating Viterra is a large, multi-year undertaking with execution, cultural, and cost risk, and the added debt and scale raise the stakes if the cycle turns. Biofuel and renewable-diesel policy shifts, tariffs, currency swings, and weather all add volatility to results. Because much of the bull case rests on a forecast earnings recovery, a shortfall against those estimates could weigh on the stock even after its strong run.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding BG already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on BG
9 analysts cover BG, with an average target of $141.44 (+30.0% against $108.79) and a split of 8 buy, 1 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the BG forecast and price target page.
How is BG valued? (as of JULY 2026)
Snapshot for BG as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$70 billion
- Net income (TTM): ~$0.8 billion
- Market cap: ~$24 billion
- Adjusted EPS (FY2025): ~$7.57
- P/E (trailing / forward): ~25x / ~15x
- Dividend yield: ~3%
Trailing revenue jumped toward $70 billion as the Viterra merger consolidates, while net income of roughly $0.8 billion reflects a softer commodity-margin year. The gap between the trailing P/E near 25x and a forward P/E near 15x captures the market's expectation of an earnings recovery in 2026 as Viterra contributes and crush margins normalize. Figures are approximate and move with the underlying commodity cycle.
How do you decide if BG is a buy?
Rather than asking whether BG is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold BG indirectly through an index or sector ETF before adding more.
What would change your mind on BG
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Viterra merger scale and synergies stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the BG stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about BG against your real portfolio and see your actual exposure before deciding.
Investing in Bunge Global SA with AI
Connect the broker you already use and ask Walnut's AI how BG fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is BG a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Viterra merger scale and synergies, with revenue (ttm) at ~$70 billion. The bear case rests on bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply. Analysts covering it are spread from $116.00 to $150.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell BG?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $116.00, +6.6% from the $108.79 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for BG?
+
Viterra merger scale and synergies. The completed Viterra combination roughly doubles Bunge's trailing revenue base toward $70 billion and adds a leading grain-trading and origination network to Bunge's oilseed-processing strength. The most optimistic analyst target on BG is $150.00, +37.9% from the $108.79 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for BG?
+
Bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply. Expanded soybean and corn production in Brazil and Argentina intensifies competition and can pressure US export economics and margins. Integrating Viterra is a large, multi-year undertaking with execution, cultural, and cost risk, and the added debt and scale raise the stakes if the cycle turns. Biofuel and renewable-diesel policy shifts, tariffs, currency swings, and weather all add volatility to results. Because much of the bull case rests on a forecast earnings recovery, a shortfall against those estimates could weigh on the stock even after its strong run. The most pessimistic published target is $116.00, +6.6% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does Bunge Global SA do?
+
Bunge Global SA is a leading global agribusiness and food company that sources, stores, processes, transports, and sells agricultural commodities and food ingredients.
What would have to change for BG to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Viterra merger scale and synergies) stalling in the reported numbers rather than in the narrative, the risk above (bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does Bunge Global (BG) do?
+
Bunge is a global agribusiness that sources, stores, processes, transports, and sells agricultural commodities and food ingredients. It is one of the world's largest oilseed processors and grain traders, operating across Agribusiness, Refined and Specialty Oils, and Milling segments.
What happened with the Bunge-Viterra merger?
+
Bunge completed its roughly $8 billion merger with Glencore-backed Viterra in July 2025, combining a top oilseed processor with a leading grain trader to form a group valued near $25 billion. The deal is meant to broaden Bunge's footprint and reduce reliance on any single commodity cycle.
Is BG a good investment?
+
That depends on your goals, time horizon, and risk tolerance, and Walnut is not an investment adviser. BG is a cyclical commodity business whose earnings swing with crush margins and trade flows, so it behaves very differently from a steady grower. Consider how that volatility fits your own portfolio and do your own research.
Walnut is informational, not investment advice, and gives no verdict on BG. Analyst targets referenced here come from a July 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.
Guides that feature BG
BG is one of the names covered in these guides. Each one puts the stock next to its peers so you can see where it fits rather than judging it alone.